Here are relevant reports on : eTMF-Study
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Polymerase Chain Reaction Market – Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study
Polymerase chain reaction (PCR) is one of the revolutionary life science technologies that has not only made tremendous impact on the scientific community, but also affected many aspects of diseases diagnosis and treatment. The overall market for Polymerase chain reaction (PCR) technology has observed steady growth due to the expansion in its application areas and increased accuracy and precision. Specific technology segments of the PCR market, such as dPCR (digital PCR) and qPCR (real-time PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Electronic Trial Master File (eTMF) Systems Market by Offering (Integrated, Standalone), Function (Analytic, Compliance, Workflow, Audit), Therapeutic (Onco, Cardio, Neuro), End User (Pharma, Biotech, MedDevice), Phase, Region - Global Forecast to 2030
The global electronic trial master file (eTMF) systems market, valued at US$1.21 billion in 2024, stood at US$1.36 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2024 to 2030, culminating in a forecasted valuation of US$2.49 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Europe eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Opportunities, Trends, Market Share - Forecast to 2030
The Europe eClinical solutions market, valued at US$2.82 billion in 2024, stood at US$3.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2030, culminating in a forecasted valuation of US$5.86 billion by the end of the period. This growth is driven by the increasing shift toward digital and decentralized clinical trial models enabled by CTR and CTIS adoption.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
China Semiconductor Industry – Expansion Plans Analysis and Trends (Government Policies and Guidelines, Import and Export Impact on Trade Partners, Key Concepts, Case Study, Key Strategies Adopted, Future Plans, and Recommendation to Players) - 2035
The China Semiconductor Industry is entering a strategically important growth phase as semiconductor demand increasingly intersects with artificial intelligence (AI), connected devices, electric vehicles (EVs), industrial automation, cloud computing, and digital infrastructure. Growth is being supported by China's enormous electronics manufacturing base, rising domestic semiconductor consumption, AI infrastructure investment, automotive electrification, 5G and IoT deployment, smart factories, robotics, and the localization of semiconductor manufacturing.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Analytics), Phase, Trial (Decentralized), Therapy (Onco, Cardio, Neuro, Rare Disease), End User (CRO, Pharma & Biotech) - Forecast to 2031
The global eClinical solutions market is projected to reach USD 31.32 billion by 2031, growing at a CAGR of 14.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Trends, Growth, Market Insight - Forecast to 2030
The Asia Pacific eClinical solutions market, valued at US$2.08 billion in 2024, stood at US$2.39 billion in 2025 and is projected to advance at a resilient CAGR of 15.4% from 2024 to 2030, culminating in a forecasted valuation of US$4.88 billion by the end of the period. The Asia Pacific eClinical solutions market is experiencing rapid growth, driven by increasing clinical trial activity, expanding digital infrastructure, and the rising adoption of advanced technologies across the region’s research ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech) Regulatory, Al, Growth, Market Size - Forecast to 2030
US eClinical solutions market, valued at US$5.26 billion in 2024, stood at US$5.99 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2025 to 2030, culminating in a forecasted valuation of US$11.64 billion by the end of the period. The growth is driven by the rising number of clinical trials conducted across major research hubs, particularly in oncology, immunology, and rare diseases.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 1 to 8 of 8
